S2M S2Medical AB (publ)

0.0003USD0.0032 SEK · STO0.00%Mkt Cap: 384067 USDP/E: —

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT…

Key Statistics

Company
Market Cap384.07K USD
Enterprise Value230.10K USD
Revenue (TTM)1.47M USD
Gross Profit1.38M USD
Net Income (TTM)-993.51K USD
Revenue/Share0.0017 USD
Last Price0.0003 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINSE0011725084
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.72
EV/Revenue0.16
P/S0.26
P/B0.29
EPS (TTM)-0.0010 USD
EPS (Forward)—
52W Range
0.00032% of range0.0015
52W High0.0015 USD
52W Low0.0003 USD
Profitability
Gross Margin97.78%
Oper. Margin-12.98%
EBITDA Margin-9.14%
Profit Margin-70.28%
ROE-102.23%
ROA-59.72%
ROIC-29.70%
ROCE-26.97%
Growth
Revenue Growth7.80%
Earnings Growth6.30%
Cash Flow & Leverage
Operating CF66.56K USD
CapEx (TTM)199.25K USD
FCF Margin-8.23%
FCF Yield-31.42%
Net Debt-55.51K USD
Net Debt/EBITDA0.41
Net Debt/FCF—
Balance Sheet
Debt/Equity0.00
Current Ratio0.58
Quick Ratio0.34
Book Value/Sh0.0011 USD
Cash/Share0.0001 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.21B
Float—
Insiders31.17%
Institutions10.07%
Technical
SMA 500.0004 (-22.3%)
SMA 2000.0006 (-49.3%)
Beta2.25
S&P 52W Chg12.00%
Avg Vol (30d)4.33M
Avg Vol (10d)4.78M
Technical Indicators
RSI (14)36.1
MACD-0.0002
MACD Signal-0.0002
MACD Hist.+0.0000
BB Upper0.0004 USD
BB Middle0.0003 USD
BB Lower0.0003 USD
BB Width24.07%
ATR (14)0.0000 USD
Vol Ratio (20d)0.10x

About S2Medical (STO: S2M)

›

S2Medical (STO: S2M) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 10 employees.

The shares were at 0.0032 SEK on 19 November 2026, down 69.2% over 52 weeks. Its 52-week range is 0.0030 SEK to 0.0150 SEK: the price is 78.7% below the high and 6.7% above the low.

Its market capitalisation is 3.90M SEK.

S2Medical reports return on equity of -102.2%, an operating margin of -13.0% and revenue up 7.8% year over year.

It holds more cash than debt, a net cash position of 564.00K SEK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.